Phoenix Molecular Designs Announces $12 Million in Seed Financing

Written by Guest User

Nov. 20
2019

SAN DIEGO and VANCOUVER, British Columbia, Nov. 20, 2019 - PhoenixMD have completed their most recent round of seed financing, resulting in a total raised to date of $12M.

Read the story here

Guest User
Previous

Phoenix Molecular Designs Initiates its Phase 1/1b Program to Evaluate PMD-026 in Patients with Resistant Forms of Advanced Breast Cancer
Next

Phoenix Molecular Designs Receives FDA Clearance to Begin Phase 1/1b Clinical Trial with PMD-026, a First-in-Class RSK Inhibitor, Targeting Advanced Breast Cancer